Digital Technology in Diabetes Care

Friday, March 24, 2023

2:15 PM – 3:45 PM

Location: Convention Center, Room 126ABC

CPE Credit 1.5 Hours

Continuing Pharmacy Education (CPE) Credit

ACPE Number: 0202-0000-23-104-L01-P
Activity Type: Knowledge
Number of Hours: 1.5

Speaker(s)

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP

Endocrine Clinical Pharmacy Specialist/CGM Program Coordinator
Cleveland Clinic
Cleveland, Ohio

Presentation PDF
Katelyn O'Brien, PharmD, BCPS, CDCES, BC-ADM (she/her/hers)

Clinical Pharmacy Specialist
Boston Medical Center
Dorchester, Massachusetts

Disclosure(s):

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP: Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bayer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Dexcom: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Insulet: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Lilly: Consultant (Ongoing); Medtronic: Advisory Committee/Board Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novo Nordisk: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Consultant (Ongoing)

Katelyn O'Brien, PharmD, BCPS, CDCES, BC-ADM: No financial relationships to disclose

The digital world has a myriad of technology to improve the management and participation of patients with diabetes. This session will share cutting-edge information on the latest products and features, highlighting improved outcomes, challenges to implementation or use, and approaches to overcome barriers.

This activity is sponsored by an independent educational grant from Abbott.

Learning Objectives:

Describe new technologies for people with diabetes including continuous glucose monitoring, connected insulin pens and corresponding mobile applications.
Determine which patients are most appropriate for diverse types of diabetes technologies.
Apply clinical practice pearls and patient education techniques to best support the patients with diabetes using new and evolving diabetes technologies.
Describe strategies to increase utilization of diabetes technology for those with disabilities and disparities in access to healthcare.